De Stefano, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 8.879
AS - Asia 7.545
EU - Europa 6.896
SA - Sud America 1.661
AF - Africa 217
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.235
Nazione #
US - Stati Uniti d'America 8.582
SG - Singapore 3.729
DE - Germania 1.695
CN - Cina 1.533
BR - Brasile 1.343
SE - Svezia 1.179
IT - Italia 1.069
VN - Vietnam 775
FR - Francia 640
UA - Ucraina 489
IE - Irlanda 368
GB - Regno Unito 363
IN - India 274
FI - Finlandia 270
ID - Indonesia 261
PL - Polonia 256
RU - Federazione Russa 183
JP - Giappone 182
HK - Hong Kong 146
AR - Argentina 132
CA - Canada 126
MX - Messico 109
IQ - Iraq 105
BD - Bangladesh 86
TR - Turchia 85
AT - Austria 74
ZA - Sudafrica 56
NL - Olanda 55
PK - Pakistan 52
ES - Italia 48
SA - Arabia Saudita 42
BE - Belgio 41
EC - Ecuador 40
KR - Corea 40
VE - Venezuela 34
CO - Colombia 33
CI - Costa d'Avorio 29
MA - Marocco 25
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
IR - Iran 23
AU - Australia 22
CL - Cile 22
PY - Paraguay 21
AE - Emirati Arabi Uniti 20
LT - Lituania 20
PH - Filippine 19
DZ - Algeria 18
KE - Kenya 18
AZ - Azerbaigian 16
JO - Giordania 16
RO - Romania 16
TN - Tunisia 16
CH - Svizzera 15
PE - Perù 15
EG - Egitto 14
OM - Oman 14
NP - Nepal 13
IL - Israele 12
JM - Giamaica 12
UY - Uruguay 12
MY - Malesia 11
CR - Costa Rica 10
PT - Portogallo 10
TH - Thailandia 10
DO - Repubblica Dominicana 9
HU - Ungheria 9
KZ - Kazakistan 9
LB - Libano 9
ET - Etiopia 8
GR - Grecia 8
MD - Moldavia 8
SN - Senegal 8
AL - Albania 7
BO - Bolivia 7
LV - Lettonia 7
BG - Bulgaria 6
HR - Croazia 6
NO - Norvegia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AM - Armenia 5
BH - Bahrain 5
DK - Danimarca 5
EE - Estonia 5
HN - Honduras 5
NI - Nicaragua 5
PA - Panama 5
TW - Taiwan 5
BY - Bielorussia 4
GT - Guatemala 4
KG - Kirghizistan 4
LY - Libia 4
NG - Nigeria 4
BB - Barbados 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
PR - Porto Rico 3
RS - Serbia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 25.184
Città #
Singapore 2.003
Chandler 1.169
Ashburn 852
San Jose 805
Dublin 360
Beijing 305
Jacksonville 277
San Mateo 277
Munich 254
Ho Chi Minh City 251
Los Angeles 230
Jakarta 223
Dallas 213
Warsaw 212
Wilmington 212
New York 209
Lauterbourg 206
Rome 197
Hanoi 195
Nanjing 187
Boston 168
Milan 167
Ann Arbor 161
Cattolica 160
Tokyo 150
Fairfield 147
Dearborn 143
Hefei 133
Hong Kong 131
Houston 123
Woodbridge 122
Helsinki 110
Frankfurt am Main 109
Moscow 104
São Paulo 101
Princeton 100
Marseille 95
Redmond 95
Chicago 92
Seattle 91
The Dalles 91
Lawrence 90
Redwood City 75
Nanchang 68
Hyderabad 64
Buffalo 58
Council Bluffs 52
Orem 52
Santa Clara 51
Da Nang 49
Nuremberg 49
Nürnberg 49
Rio de Janeiro 47
Paris 46
Bremen 43
Boardman 42
London 40
Belo Horizonte 38
Brussels 37
Kent 37
Norwalk 37
Hebei 35
Montreal 35
Seoul 35
Baghdad 34
Toronto 34
Johannesburg 33
Kunming 33
Mountain View 33
Vienna 33
Guangzhou 32
Haiphong 32
Cambridge 31
Atlanta 30
Hangzhou 30
University Park 30
Zhengzhou 30
Abidjan 29
Brooklyn 29
Mexico City 29
San Francisco 29
Shanghai 29
Tianjin 29
Shenyang 28
Washington 28
Detroit 27
Florence 27
Düsseldorf 26
Jiaxing 26
Lancaster 26
Poplar 26
Pune 26
Dhaka 25
Izmir 25
Leawood 25
St Louis 25
Turku 25
Curitiba 23
Kraków 23
Tashkent 23
Totale 13.382
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 339
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 328
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 324
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 284
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 251
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 243
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 241
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 240
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 221
A real-time integrated framework to support clinical decision making for covid-19 patients 197
Risk factor and etiology analysis of ischemic stroke in young adult patients 195
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 192
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 191
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 189
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 188
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 183
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 180
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 179
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 177
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 174
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 172
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 172
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 168
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 167
Venous thromboembolism in multiple myeloma 166
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 166
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 165
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 164
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 163
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 161
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 161
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 158
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 156
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 155
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 153
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 152
Postpartum hemorrhage 147
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 147
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 147
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 145
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 144
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 143
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 143
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 143
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 142
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 141
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 140
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 139
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 138
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 138
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 136
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 136
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 135
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 134
Ineherited Thrombophilia: treatment during pregnancy 134
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 134
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 133
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 133
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 132
Inherited thrombophilia: treatment during pregnancy. 129
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 128
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 128
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 127
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 125
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 125
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 122
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 122
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 121
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 121
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 120
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 119
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 119
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 118
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 117
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 116
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 115
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 115
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 114
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 113
THE IMPACT OF EDUCATION ON PATIENTS' PSYCHOEMOTIONAL STATUS DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE PROSPECTIVE STUDY BY THE GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO 112
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 112
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 112
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation 112
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: A survey by the GIMEMA Haemostasis and Thrombosis Working Party 111
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 111
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 111
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 110
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 106
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 105
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 105
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 104
Totale 15.466
Categoria #
all - tutte 108.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.952


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021344 0 0 0 0 0 0 0 0 0 47 271 26
2021/20221.674 130 103 25 76 100 29 24 259 81 108 320 419
2022/20233.370 509 476 294 484 206 378 178 226 368 91 110 50
2023/20241.742 74 506 57 78 77 234 107 96 32 60 188 233
2024/20254.006 98 135 275 122 337 114 217 215 638 392 766 697
2025/20269.598 1.528 320 761 1.125 1.830 523 1.697 491 688 635 0 0
Totale 25.596